1.
对照组、阵发性房颤组、持续性房颤组患者基线资料比较
Baseline data of the patients in the control group, paroxysmal AF (PaAF) group and persistentAF (PeAF) group
| Variable | CON (n=80) | PaAF (n=66) | PeAF (n=72) | F/χ2 | P |
| RBC: Red blood bell, WBC: White blood bell, PLT: Platelet, BNP: Brain natriuretic peptide, LVEF: Left ventricular ejection fraction, ALT: Alanine aminotransferase, AST: Aspartate aminotransferase, SCR: Serum creatinine, LDL: Low-density lipoprotein. | |||||
| Age (year) | 63.85±10.29 | 65.02±11.12 | 66.71±8.95 | 1.52 | |
| Male (n, %) | 44 (55) | 36(54.55) | 43 (65.15) | 0.48 | |
| Smoking (n, %) | 16 (20) | 11 (16.67) | 15 (20.83) | 0.43 | |
| Hypertension (n, %) | 42 (52.5) | 29(43.94) | 40 (55.56) | 1.99 | |
| Diabetes mellitus (n, %) | 6 (7.5) | 8(12.12) | 12 (16.67) | 3.03 | |
| Cerebral infarction (n, %) | 15 (18.75) | 10(15.15) | 16 (22.22) | 1.13 | |
| Anticoagulant (n, %) | 0 (0) | 66 (100) | 72 (100) | - | |
| Amiodarone (n, %) | 0 (0) | 66 (100) | 72 (100) | - | |
| RBC/(×1012/L) | 4.47±0.36 | 4.40±0.64 | 4.36±0.8 | 0.59 | >0.05 |
| WBC/(×109/L) | 5.80±1.40 | 5.85±1.38 | 6.32±1.91 | 2.39 | |
| PLT/(×109/L) | 204.63±53.82 | 216.18±56.18 | 200.79±49.38 | 1.56 | |
| BNP (pg/mL) | 51.57±39.98 | 53.11±32.41 | 45.91±21.09 | 1.11 | |
| LVEF (%) | 56.56±5.05 | 54.85±6.62 | 56.95±5.91 | 2.64 | |
| ALT (U/L) | 23.26±5.86 | 22.05±11.69 | 22.42±9.87 | 1.18 | |
| AST (U/L) | 23.79±7.64 | 26.98±13.59 | 26.79±11.98 | 1.95 | |
| SCR (μmol/L) | 63.94±8.67 | 63.64±14.80 | 66.71±16.85 | 1.10 | |
| LDL (mmol/L) | 2.50±0.52 | 2.33±0.66 | 2.49±0.86 | 1.32 | |